• Home
  • Pharmaceuticals and Healthcare
Jakinibs Market, Global Outlook and Forecast 2024-2030

Jakinibs Market, Global Outlook and Forecast 2024-2030

Report Code: KNJ1766184 | No. of Pages: 119 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Mar-2024 
This research report provides a comprehensive analysis of the Jakinibs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Jakinibs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Jakinibs, challenges faced by the industry, and potential opportunities for market players.
The global Jakinibs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Jakinibs market presents opportunities for various stakeholders, including Rheumatoid Arthritis, Inflammatory Bowel Disease. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Jakinibs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Jakinibs market was valued at US$ 13780 million in 2023 and is projected to reach US$ 32440 million by 2030, at a CAGR of 13.1% during the forecast period.
The driving factors of the Janus Kinase (JAK) inhibitor market mainly include the following aspects:

Increase in immune system diseases: JAK inhibitors are commonly used to treat immune system-related diseases such as rheumatoid arthritis, Sjogren's syndrome, inflammatory bowel disease, and psoriasis. As the incidence of these diseases continues to increase, the JAK inhibitor market is also expanding.

Research and development of innovative drugs: Pharmaceutical companies continue to invest in the development of new generations of JAK inhibitors to improve treatment efficacy and reduce side effects. The launch of these innovative drugs drives the growth of the market.

Aging Global Population: As the global population ages, the risk of developing immune system-related diseases increases. This will drive demand for drugs such as JAK inhibitors to address health challenges in the elderly population.
Key Features:
The research report on the Jakinibs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Jakinibs market.
Market Overview: The report provides a comprehensive overview of the Jakinibs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., JAK1 Inhibitors, JAK2 Inhibitors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Jakinibs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Jakinibs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Jakinibs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Jakinibs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Jakinibs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Jakinibs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Jakinibs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Jakinibs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Jakinibs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
    JAK1 Inhibitors
    JAK2 Inhibitors
    JAK3 Inhibitors
Market segment by Application
    Rheumatoid Arthritis
    Inflammatory Bowel Disease
    Psoriasis
    Others
Global Jakinibs Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Astellas Pharma, Inc.
    Eli Lilly and Co.
    Incyte Corp.
    Novartis AG
    Pfizer Inc.
    GSK
    Bristol Myers Squibb Co.
    Baxter International, Inc.
    Gilead Sciences, Inc.
    AbbVie, Inc.
    Takeda
    Boehringer Ingelheim Group
    Teva Pharmaceutical
    Kyowa Hakko Kirin Co. Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Jakinibs, market overview.
Chapter 2: Global Jakinibs market size in revenue and volume.
Chapter 3: Detailed analysis of Jakinibs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Jakinibs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Jakinibs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
    1.1 Jakinibs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Jakinibs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Jakinibs Overall Market Size
    2.1 Global Jakinibs Market Size: 2023 VS 2030
    2.2 Global Jakinibs Revenue, Prospects & Forecasts: 2019-2030
    2.3 Global Jakinibs Sales: 2019-2030
3 Company Landscape
    3.1 Top Jakinibs Players in Global Market
    3.2 Top Global Jakinibs Companies Ranked by Revenue
    3.3 Global Jakinibs Revenue by Companies
    3.4 Global Jakinibs Sales by Companies
    3.5 Global Jakinibs Price by Manufacturer (2019-2024)
    3.6 Top 3 and Top 5 Jakinibs Companies in Global Market, by Revenue in 2023
    3.7 Global Manufacturers Jakinibs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Jakinibs Players in Global Market
        3.8.1 List of Global Tier 1 Jakinibs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Jakinibs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Jakinibs Market Size Markets, 2023 & 2030
        4.1.2 JAK1 Inhibitors
        4.1.3 JAK2 Inhibitors
        4.1.4 JAK3 Inhibitors
    4.2 By Type - Global Jakinibs Revenue & Forecasts
        4.2.1 By Type - Global Jakinibs Revenue, 2019-2024
        4.2.2 By Type - Global Jakinibs Revenue, 2025-2030
        4.2.3 By Type - Global Jakinibs Revenue Market Share, 2019-2030
    4.3 By Type - Global Jakinibs Sales & Forecasts
        4.3.1 By Type - Global Jakinibs Sales, 2019-2024
        4.3.2 By Type - Global Jakinibs Sales, 2025-2030
        4.3.3 By Type - Global Jakinibs Sales Market Share, 2019-2030
    4.4 By Type - Global Jakinibs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Jakinibs Market Size, 2023 & 2030
        5.1.2 Rheumatoid Arthritis
        5.1.3 Inflammatory Bowel Disease
        5.1.4 Psoriasis
        5.1.5 Others
    5.2 By Application - Global Jakinibs Revenue & Forecasts
        5.2.1 By Application - Global Jakinibs Revenue, 2019-2024
        5.2.2 By Application - Global Jakinibs Revenue, 2025-2030
        5.2.3 By Application - Global Jakinibs Revenue Market Share, 2019-2030
    5.3 By Application - Global Jakinibs Sales & Forecasts
        5.3.1 By Application - Global Jakinibs Sales, 2019-2024
        5.3.2 By Application - Global Jakinibs Sales, 2025-2030
        5.3.3 By Application - Global Jakinibs Sales Market Share, 2019-2030
    5.4 By Application - Global Jakinibs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
    6.1 By Region - Global Jakinibs Market Size, 2023 & 2030
    6.2 By Region - Global Jakinibs Revenue & Forecasts
        6.2.1 By Region - Global Jakinibs Revenue, 2019-2024
        6.2.2 By Region - Global Jakinibs Revenue, 2025-2030
        6.2.3 By Region - Global Jakinibs Revenue Market Share, 2019-2030
    6.3 By Region - Global Jakinibs Sales & Forecasts
        6.3.1 By Region - Global Jakinibs Sales, 2019-2024
        6.3.2 By Region - Global Jakinibs Sales, 2025-2030
        6.3.3 By Region - Global Jakinibs Sales Market Share, 2019-2030
    6.4 North America
        6.4.1 By Country - North America Jakinibs Revenue, 2019-2030
        6.4.2 By Country - North America Jakinibs Sales, 2019-2030
        6.4.3 US Jakinibs Market Size, 2019-2030
        6.4.4 Canada Jakinibs Market Size, 2019-2030
        6.4.5 Mexico Jakinibs Market Size, 2019-2030
    6.5 Europe
        6.5.1 By Country - Europe Jakinibs Revenue, 2019-2030
        6.5.2 By Country - Europe Jakinibs Sales, 2019-2030
        6.5.3 Germany Jakinibs Market Size, 2019-2030
        6.5.4 France Jakinibs Market Size, 2019-2030
        6.5.5 U.K. Jakinibs Market Size, 2019-2030
        6.5.6 Italy Jakinibs Market Size, 2019-2030
        6.5.7 Russia Jakinibs Market Size, 2019-2030
        6.5.8 Nordic Countries Jakinibs Market Size, 2019-2030
        6.5.9 Benelux Jakinibs Market Size, 2019-2030
    6.6 Asia
        6.6.1 By Region - Asia Jakinibs Revenue, 2019-2030
        6.6.2 By Region - Asia Jakinibs Sales, 2019-2030
        6.6.3 China Jakinibs Market Size, 2019-2030
        6.6.4 Japan Jakinibs Market Size, 2019-2030
        6.6.5 South Korea Jakinibs Market Size, 2019-2030
        6.6.6 Southeast Asia Jakinibs Market Size, 2019-2030
        6.6.7 India Jakinibs Market Size, 2019-2030
    6.7 South America
        6.7.1 By Country - South America Jakinibs Revenue, 2019-2030
        6.7.2 By Country - South America Jakinibs Sales, 2019-2030
        6.7.3 Brazil Jakinibs Market Size, 2019-2030
        6.7.4 Argentina Jakinibs Market Size, 2019-2030
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Jakinibs Revenue, 2019-2030
        6.8.2 By Country - Middle East & Africa Jakinibs Sales, 2019-2030
        6.8.3 Turkey Jakinibs Market Size, 2019-2030
        6.8.4 Israel Jakinibs Market Size, 2019-2030
        6.8.5 Saudi Arabia Jakinibs Market Size, 2019-2030
        6.8.6 UAE Jakinibs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
    7.1 Astellas Pharma, Inc.
        7.1.1 Astellas Pharma, Inc. Company Summary
        7.1.2 Astellas Pharma, Inc. Business Overview
        7.1.3 Astellas Pharma, Inc. Jakinibs Major Product Offerings
        7.1.4 Astellas Pharma, Inc. Jakinibs Sales and Revenue in Global (2019-2024)
        7.1.5 Astellas Pharma, Inc. Key News & Latest Developments
    7.2 Eli Lilly and Co.
        7.2.1 Eli Lilly and Co. Company Summary
        7.2.2 Eli Lilly and Co. Business Overview
        7.2.3 Eli Lilly and Co. Jakinibs Major Product Offerings
        7.2.4 Eli Lilly and Co. Jakinibs Sales and Revenue in Global (2019-2024)
        7.2.5 Eli Lilly and Co. Key News & Latest Developments
    7.3 Incyte Corp.
        7.3.1 Incyte Corp. Company Summary
        7.3.2 Incyte Corp. Business Overview
        7.3.3 Incyte Corp. Jakinibs Major Product Offerings
        7.3.4 Incyte Corp. Jakinibs Sales and Revenue in Global (2019-2024)
        7.3.5 Incyte Corp. Key News & Latest Developments
    7.4 Novartis AG
        7.4.1 Novartis AG Company Summary
        7.4.2 Novartis AG Business Overview
        7.4.3 Novartis AG Jakinibs Major Product Offerings
        7.4.4 Novartis AG Jakinibs Sales and Revenue in Global (2019-2024)
        7.4.5 Novartis AG Key News & Latest Developments
    7.5 Pfizer Inc.
        7.5.1 Pfizer Inc. Company Summary
        7.5.2 Pfizer Inc. Business Overview
        7.5.3 Pfizer Inc. Jakinibs Major Product Offerings
        7.5.4 Pfizer Inc. Jakinibs Sales and Revenue in Global (2019-2024)
        7.5.5 Pfizer Inc. Key News & Latest Developments
    7.6 GSK
        7.6.1 GSK Company Summary
        7.6.2 GSK Business Overview
        7.6.3 GSK Jakinibs Major Product Offerings
        7.6.4 GSK Jakinibs Sales and Revenue in Global (2019-2024)
        7.6.5 GSK Key News & Latest Developments
    7.7 Bristol Myers Squibb Co.
        7.7.1 Bristol Myers Squibb Co. Company Summary
        7.7.2 Bristol Myers Squibb Co. Business Overview
        7.7.3 Bristol Myers Squibb Co. Jakinibs Major Product Offerings
        7.7.4 Bristol Myers Squibb Co. Jakinibs Sales and Revenue in Global (2019-2024)
        7.7.5 Bristol Myers Squibb Co. Key News & Latest Developments
    7.8 Baxter International, Inc.
        7.8.1 Baxter International, Inc. Company Summary
        7.8.2 Baxter International, Inc. Business Overview
        7.8.3 Baxter International, Inc. Jakinibs Major Product Offerings
        7.8.4 Baxter International, Inc. Jakinibs Sales and Revenue in Global (2019-2024)
        7.8.5 Baxter International, Inc. Key News & Latest Developments
    7.9 Gilead Sciences, Inc.
        7.9.1 Gilead Sciences, Inc. Company Summary
        7.9.2 Gilead Sciences, Inc. Business Overview
        7.9.3 Gilead Sciences, Inc. Jakinibs Major Product Offerings
        7.9.4 Gilead Sciences, Inc. Jakinibs Sales and Revenue in Global (2019-2024)
        7.9.5 Gilead Sciences, Inc. Key News & Latest Developments
    7.10 AbbVie, Inc.
        7.10.1 AbbVie, Inc. Company Summary
        7.10.2 AbbVie, Inc. Business Overview
        7.10.3 AbbVie, Inc. Jakinibs Major Product Offerings
        7.10.4 AbbVie, Inc. Jakinibs Sales and Revenue in Global (2019-2024)
        7.10.5 AbbVie, Inc. Key News & Latest Developments
    7.11 Takeda
        7.11.1 Takeda Company Summary
        7.11.2 Takeda Business Overview
        7.11.3 Takeda Jakinibs Major Product Offerings
        7.11.4 Takeda Jakinibs Sales and Revenue in Global (2019-2024)
        7.11.5 Takeda Key News & Latest Developments
    7.12 Boehringer Ingelheim Group
        7.12.1 Boehringer Ingelheim Group Company Summary
        7.12.2 Boehringer Ingelheim Group Business Overview
        7.12.3 Boehringer Ingelheim Group Jakinibs Major Product Offerings
        7.12.4 Boehringer Ingelheim Group Jakinibs Sales and Revenue in Global (2019-2024)
        7.12.5 Boehringer Ingelheim Group Key News & Latest Developments
    7.13 Teva Pharmaceutical
        7.13.1 Teva Pharmaceutical Company Summary
        7.13.2 Teva Pharmaceutical Business Overview
        7.13.3 Teva Pharmaceutical Jakinibs Major Product Offerings
        7.13.4 Teva Pharmaceutical Jakinibs Sales and Revenue in Global (2019-2024)
        7.13.5 Teva Pharmaceutical Key News & Latest Developments
    7.14 Kyowa Hakko Kirin Co. Ltd.
        7.14.1 Kyowa Hakko Kirin Co. Ltd. Company Summary
        7.14.2 Kyowa Hakko Kirin Co. Ltd. Business Overview
        7.14.3 Kyowa Hakko Kirin Co. Ltd. Jakinibs Major Product Offerings
        7.14.4 Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales and Revenue in Global (2019-2024)
        7.14.5 Kyowa Hakko Kirin Co. Ltd. Key News & Latest Developments
8 Global Jakinibs Production Capacity, Analysis
    8.1 Global Jakinibs Production Capacity, 2019-2030
    8.2 Jakinibs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Jakinibs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Jakinibs Supply Chain Analysis
    10.1 Jakinibs Industry Value Chain
    10.2 Jakinibs Upstream Market
    10.3 Jakinibs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Jakinibs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com